Uso del producto: Este producto está destinado exclusivamente a la investigación.
Toda la información de los productos de este sitio web tiene fines exclusivamente educativos. Cualquier forma de introducción en el cuerpo de personas o animales está estrictamente prohibida por la ley. Este producto solo debe ser manipulado por profesionales autorizados y cualificados. No es un medicamento, alimento ni cosmético y no debe etiquetarse, utilizarse ni presentarse como tal.
Dihexa – Powder, 500mg
Durante el cambio de envase, puedes recibir productos con la etiqueta anterior o con la nueva. La formulación, la pureza y la calidad siguen siendo exactamente las mismas, según nuestros estándares.
- Tarjeta de crédito
- Transferencia bancaria (SEPA inmediata)
- Transferencia bancaria (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Otros
-25% en todo – hasta el 31 de octubre
25% sobre los precios habituales, en sustitución de otras ofertas. Acumulable solo con el descuento crypto.
Envío en el día para pedidos en EE. UU. realizados antes de las 12:00 EST.
Ver la política de envíos →Devoluciones sin complicaciones en 30 días para productos sin abrir.
Ver la política de devoluciones →Cada lote se analiza para comprobar su pureza, potencia y calidad.
Ver resultados de laboratorio →Dihexa (PNB-0408) is a synthetic heptapeptide analogue of angiotensin IV designed to interact with the hepatocyte growth factor (HGF)/c-Met signaling system. Experimental investigations have demonstrated that Dihexa modulates HGF-associated signaling pathways involved in cellular communication, synaptic regulatory mechanisms, and receptor-mediated signal transduction.
Research has examined its effects on c-Met receptor activation, downstream kinase signaling networks, dendritic architecture regulation, and molecular processes associated with synaptic structure and connectivity.
These characteristics make Dihexa a valuable research tool for studies of HGF/c-Met pharmacology, synaptogenesis-associated signaling pathways, receptor-mediated regulatory mechanisms, and comparative investigations of compounds influencing neuronal signaling networks.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C27H44N4O5 |
|---|---|
| Synonyms | PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide |
| Molar Mass | 504.67 g/mol |
| CAS Number | 1401708-83-5 |
| PubChem CID | 129010512 |
| Total Compound Content | 500 mg powder |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What is the mechanism by which Dihexa modulates HGF/c-Met signalling?
Experimental investigations indicate that Dihexa interacts with the hepatocyte growth factor (HGF)/c-Met signaling system through modulation of HGF-associated molecular interactions rather than direct activation of the c-Met receptor.
Research has examined its influence on HGF-dependent signaling processes, receptor-mediated signal transduction, and downstream regulatory pathways associated with c-Met activation. This mechanism makes Dihexa a valuable tool for studies of HGF/c-Met pharmacology, growth factor signaling, and receptor-associated regulatory networks.
What research findings have generated interest in Dihexa's synaptogenesis-associated activity?
Published experimental investigations have reported effects of Dihexa on signaling pathways associated with synaptic structure, dendritic architecture regulation, and receptor-mediated mechanisms involved in synaptogenesis.
These findings have generated significant research interest in the compound as a tool for investigating HGF/c-Met-associated signaling networks, synaptic regulatory processes, and molecular pathways governing neuronal connectivity. Continued mechanistic investigation remains an active area of research.
What is the relationship between Dihexa and angiotensin IV?
Dihexa was developed as a structurally modified analogue of angiotensin IV and retains key features of the parent scaffold while incorporating modifications designed to alter physicochemical and pharmacological properties. This structural relationship has made Dihexa useful for comparative investigations of angiotensin-derived compounds, structure-activity relationships, peptide-derived signaling modulators, and the molecular determinants governing receptor-associated signaling pathways.
